Product
Supplier
Encyclopedia
Inquiry
Home > News > Company Dynamic > BASF Inaugurates New Pharma Technical Lab in India

BASF Inaugurates New Pharma Technical Lab in India

Chemical Today News 2017-08-04

BASF India Limited, subsidiary of BASF SE has inaugurated its pharma technical lab at its Innovation Campus Asia Pacific, located in Navi Mumbai, India.

Named “BASF Pharma Solutions Lab”, the facility will cater to the fast-growing pharmaceutical market in South Asia, especially generic drug manufacturing, which accounts for more than 70 percent of the sector in India.

BASF Inaugurates New Pharma Technical Lab in India

This pharma technical lab is the fifth application lab in BASF’s global innovation network for pharmaceutical solutions, which also includes labs in Germany, North America, South America, and China.

The 200-square-meter application lab boasts technical capabilities in creating and delivering BASF’s functional solutions for drug formulation, especially in solubilization and instant & modified release. This will enable pharmaceutical manufacturers to solve drug formulation challenges such as developing fixed dose combinations, taste masking and temperature- or moisture-sensitive drugs.

Inaugurated in March of this year, the Innovation Campus Asia Pacific also houses the company’s other existing scientific disciplines. This creates the opportunity for innovation synergies to be able to meet the unique technological needs of diverse customers across South Asia.

“This technical lab in Mumbai will provide generic drug manufacturing customers with comprehensive solutions for superior product efficacy. It will also optimize the performance of raw materials in formulation,” said Tina Low, vice president, BASF nutrition & health Asia Pacific.

“South Asia, especially India, is the largest provider for generic medicines globally; and R&D is a major focus for Indian generic pharma companies, as they continue to move further up the value chain to become more competitive globally. The kind of innovation capabilities at this pharma solutions lab for generic drug manufacturing is crucial to furthering the government programs aimed at providing universal healthcare in South Asia,” said Raman Ramachandran, head South Asia and chairman and managing director, BASF India Limited.

Disclaimer: ECHEMI reserves the right of final explanation and revision for all the information.
Company-Dynamic
Comment
Comment

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.